Show simple item record

2011-06-16Zeitschriftenartikel DOI: 10.1186/1471-2334-11-173
Herpes zoster in Germany: Quantifying the burden of disease
dc.contributor.authorUltsch, Bernhard
dc.contributor.authorSiedler, Anette
dc.contributor.authorRieck, Thorsten
dc.contributor.authorReinhold, Thomas
dc.contributor.authorKrause, Gérard
dc.contributor.authorWichmann, Ole
dc.date.accessioned2018-05-07T14:41:39Z
dc.date.available2018-05-07T14:41:39Z
dc.date.created2011-08-08
dc.date.issued2011-06-16none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/re4K2mWrFdrZo/PDF/24tWMNR8Lo6.pdf
dc.identifier.urihttp://edoc.rki.de/176904/903
dc.description.abstractBackground: Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged ≥ 50 years. Vaccines have been licensed or are under development that can protect against HZ and its main complication postherpetic neuralgia (PHN). In Germany, the burden of disease caused by HZ is not well known. To support the decision making process related to a potential vaccination recommendation, we estimated annual HZ disease burden in people aged ≥ 50 years in Germany by utilizing various data sources. Methods: We assessed for 2007 and 2008 HZ-outpatient incidence (number of cases per 1,000 person-years, PY) by utilizing the Association of Statutory Health Insurance Physicians (ASHIP) database, which contains nationwide routine outpatient data. For the same time period annual number of HZ-inpatients and HZ-associated deaths were identified by using the Federal Health Monitoring System (FHM). PHN-incidence and loss of quality-adjusted life years (QALYs) caused by HZ were calculated by multiplying number of identified HZ-patients with upper and lower limit estimates for proportion of HZ-cases developing PHN and HZ-related QALY, respectively. Results: For the study period we identified an annual average of 306,511 HZ-outpatients aged 50+, resulting in a HZ-incidence of 9.6/1,000 PY. A total 14,249 HZ-associated inpatients and 66 deaths were reported in both years on average. HZ-incidence increased by age from 6.21 in people 50-54 years to 13.19 per 1,000 PY in people aged ≥ 90 years. Females were significantly more frequently affected than males in terms of outpatient HZ-incidence (11.12 vs. 7.8 per 1,000 PY), inpatient HZ-incidence (0.51 vs. 0.38 per 1,000 PY) and mortality (0.29 vs. 0.10 per 100,000 PY). PHN-incidence was estimated to range between 0.43 and 1.33 per 1,000 PY. Based on these figures, there were between 3,065 to 24,094 QALYs lost due to HZ in persons aged ≥ 50 years in Germany per annum. Conclusion: Our study provides important baseline estimates for HZ-related disease burden in Germany. HZ poses a considerable burden on the health care system in Germany both in terms of outpatient and inpatient services. Follow-up assessments of HZ disease burden are needed to monitor the impact of VZV-vaccinations in Germany.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionsepidemiologie
dc.subjectAgedeng
dc.subjectHumanseng
dc.subjectFemaleeng
dc.subjectGermany/epidemiologyeng
dc.subjectMaleeng
dc.subjectMiddle Agedeng
dc.subjectIncidenceeng
dc.subjectAged 80 and overeng
dc.subjectHospitalization/statistics & numerical dataeng
dc.subjectPoisson Distributioneng
dc.subjectCost of Illnesseng
dc.subjectCost-Benefit Analysiseng
dc.subjectHerpes Zoster/economicseng
dc.subjectHerpes Zoster/epidemiologyeng
dc.subjectHerpes Zoster/mortalityeng
dc.subjectHerpes Zoster/prevention & controleng
dc.subjectHerpes Zoster Vaccineeng
dc.subjectOutpatients/statistics & numerical dataeng
dc.subject.ddc610 Medizin
dc.titleHerpes zoster in Germany: Quantifying the burden of disease
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10014770
dc.identifier.doi10.1186/1471-2334-11-173
dc.identifier.doihttp://dx.doi.org/10.25646/828
local.edoc.container-titleBMC Infectious Diseases
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.biomedcentral.com/1471-2334/11/173
local.edoc.container-publisher-nameBioMedCentral
local.edoc.container-volume11
local.edoc.container-issue173
local.edoc.container-year2011

Show simple item record